Werewolf Therapeutics Ownership 2024 | Who Owns Werewolf Therapeutics Now?
Institutional Ownership
3.49%
Insider Ownership
6.23%
Retail Ownership
90.28%
Institutional Holders
13.00
Werewolf Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 14.77% | 0.20% | 6,144,881 | - | - | 14,993,510 | Jun 30, 2024 |
| MPM ASSET MANAGEMENT LLC | 10.30% | 5.74% | 4,284,172 | - | - | 10,453,380 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 7.79% | 0.39% | 3,241,074 | 234,340 | 7.79% | 7,908,221 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 5.74% | 0.91% | 2,388,011 | - | - | 5,826,747 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 5.16% | 0.00% | 2,147,425 | 266,312 | 14.16% | 5,239,717 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.81% | 0.01% | 2,000,594 | -1,000,000 | -33.33% | 4,881,449 | Jun 30, 2024 |
| BLACKROCK INC. | 3.82% | 0.00% | 1,587,724 | 1,422,932 | 863.47% | 3,874,046 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 3.21% | 0.09% | 1,333,893 | -287,141 | -17.71% | 3,254,699 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.18% | 0.00% | 1,323,781 | 216,434 | 19.55% | 3,230,026 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 2.67% | 0.00% | 1,110,298 | 544,881 | 96.37% | 2,709,127 | Jun 30, 2024 |
| EAGLE HEALTH INVESTMENTS LP | 1.68% | 0.30% | 700,000 | - | - | 1,708,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.55% | 0.00% | 645,297 | 385,617 | 148.50% | 1,574,736 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.51% | 0.21% | 626,810 | - | - | 1,529,416 | Jun 30, 2024 |
| DC FUNDS, LP | 1.42% | 23.87% | 589,102 | - | - | 1,437,409 | Jun 30, 2024 |
| STATE STREET CORP | 1.02% | - | 423,911 | 352,743 | 495.65% | 1,034,343,000 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.77% | 0.00% | 319,477 | 319,477 | 100.00% | 779,524 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.57% | 0.00% | 235,705 | - | - | 575,120 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.56% | 0.00% | 233,828 | -337,638 | -59.08% | 570,540 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.53% | 0.00% | 219,366 | 34,307 | 18.54% | 535,253 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.51% | 0.00% | 212,296 | 39,413 | 22.80% | 516,000 | Jun 30, 2024 |
Werewolf Therapeutics's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 14.77% of the company's total share outstanding, currently valued at $14.99M. The top 10 institutional shareholders own together 61.44% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DC FUNDS, LP | 1.42% | 23.87% | 589,102 | - | - | 1,437,409 | Jun 30, 2024 |
| MPM ASSET MANAGEMENT LLC | 10.30% | 5.74% | 4,284,172 | - | - | 10,453,380 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 5.74% | 0.91% | 2,388,011 | - | - | 5,826,747 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 7.79% | 0.39% | 3,241,074 | 234,340 | 7.79% | 7,908,221 | Jun 30, 2024 |
| EAGLE HEALTH INVESTMENTS LP | 1.68% | 0.30% | 700,000 | - | - | 1,708,000 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.51% | 0.21% | 626,810 | - | - | 1,529,416 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 14.77% | 0.20% | 6,144,881 | - | - | 14,993,510 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 3.21% | 0.09% | 1,333,893 | -287,141 | -17.71% | 3,254,699 | Jun 30, 2024 |
| MURCHINSON LTD. | 0.15% | 0.02% | 62,500 | 62,500 | 100.00% | 152,500 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.09% | 0.02% | 37,551 | 37,551 | 100.00% | 91,624 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.81% | 0.01% | 2,000,594 | -1,000,000 | -33.33% | 4,881,449 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.30% | 0.01% | 125,086 | 40,000 | 47.01% | 305,210 | Jun 30, 2024 |
| FINANCIAL PERSPECTIVES, INC | 0.02% | 0.01% | 6,750 | - | - | 16,470 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.57% | 0.00% | 235,705 | - | - | 575,120 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.56% | 0.00% | 233,828 | -337,638 | -59.08% | 570,540 | Jun 30, 2024 |
| ROYCE & ASSOCIATES LP | 0.30% | 0.00% | 125,484 | 88,163 | 236.23% | 306,181 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.47% | 0.00% | 197,377 | 159,749 | 424.55% | 481,000 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.09% | 0.00% | 37,500 | 37,500 | 100.00% | 91,500 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.77% | 0.00% | 319,477 | 319,477 | 100.00% | 779,524 | Jun 30, 2024 |
| CERTUITY, LLC | 0.02% | 0.00% | 10,000 | - | - | 24,400 | Jun 30, 2024 |
The largest Werewolf Therapeutics shareholder by % of total assets is DC FUNDS, LP. The company owns 589.10K shares of Werewolf Therapeutics (HOWL), representing 23.87% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 3.82% | 0.00% | 1,587,724 | 1,422,932 | 863.47% | 3,874,046 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 2.67% | 0.00% | 1,110,298 | 544,881 | 96.37% | 2,709,127 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.55% | 0.00% | 645,297 | 385,617 | 148.50% | 1,574,736 | Jun 30, 2024 |
| STATE STREET CORP | 1.02% | - | 423,911 | 352,743 | 495.65% | 1,034,343,000 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.77% | 0.00% | 319,477 | 319,477 | 100.00% | 779,524 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 5.16% | 0.00% | 2,147,425 | 266,312 | 14.16% | 5,239,717 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 7.79% | 0.39% | 3,241,074 | 234,340 | 7.79% | 7,908,221 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.18% | 0.00% | 1,323,781 | 216,434 | 19.55% | 3,230,026 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.47% | 0.00% | 197,377 | 159,749 | 424.55% | 481,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.32% | 0.00% | 134,184 | 107,900 | 410.52% | 327,409 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.24% | 0.00% | 98,440 | 98,440 | 100.00% | 240,194 | Jun 30, 2024 |
| ROYCE & ASSOCIATES LP | 0.30% | 0.00% | 125,484 | 88,163 | 236.23% | 306,181 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.41% | 0.00% | 171,000 | 86,800 | 103.09% | 417,240 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.19% | - | 78,842 | 78,842 | 100.00% | 192,374 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.16% | - | 67,644 | 67,644 | 100.00% | 165,050 | Jun 30, 2024 |
| MURCHINSON LTD. | 0.15% | 0.02% | 62,500 | 62,500 | 100.00% | 152,500 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.13% | 0.00% | 52,200 | 52,200 | 100.00% | 127,368 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.13% | - | 52,048 | 52,048 | 100.00% | 126,997 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.39% | 0.00% | 160,577 | 48,952 | 43.85% | 392,006 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.30% | 0.01% | 125,086 | 40,000 | 47.01% | 305,210 | Jun 30, 2024 |
As of Jun 30 2024, Werewolf Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 1.42M stocks of HOWL, valued at $3.87M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 0.40% | 0.00% | 167,987 | -1,520,067 | -90.05% | 406,529 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.81% | 0.01% | 2,000,594 | -1,000,000 | -33.33% | 4,881,449 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -890,000 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.56% | 0.00% | 233,828 | -337,638 | -59.08% | 570,540 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 3.21% | 0.09% | 1,333,893 | -287,141 | -17.71% | 3,254,699 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -201,236 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.13% | - | 52,089 | -120,705 | -69.85% | 127,097 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.02% | - | 8,315 | -108,698 | -92.89% | 20,289 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.03% | - | 13,075 | -58,109 | -81.63% | 31,903 | Jun 30, 2024 |
| MAN GROUP PLC | 0.11% | 0.00% | 44,481 | -35,158 | -44.15% | 108,534 | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -26,600 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -25,240 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -24,594 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -23,659 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -23,264 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -18,910 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -14,154 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.03% | - | 10,459 | -12,589 | -54.62% | 25,520 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.07% | 0.00% | 28,371 | -12,278 | -30.20% | 69,224 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -10,800 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Werewolf Therapeutics's biggest institutional seller is JANUS HENDERSON GROUP PLC. The company sold -1.52M shares of HOWL, valued at $406.53K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 0.77% | 0.00% | 319,477 | 319,477 | 100.00% | 779,524 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.24% | 0.00% | 98,440 | 98,440 | 100.00% | 240,194 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.19% | - | 78,842 | 78,842 | 100.00% | 192,374 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.16% | - | 67,644 | 67,644 | 100.00% | 165,050 | Jun 30, 2024 |
| MURCHINSON LTD. | 0.15% | 0.02% | 62,500 | 62,500 | 100.00% | 152,500 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.13% | 0.00% | 52,200 | 52,200 | 100.00% | 127,368 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.13% | - | 52,048 | 52,048 | 100.00% | 126,997 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.10% | 0.00% | 39,900 | 39,900 | 100.00% | 97,000 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.09% | 0.02% | 37,551 | 37,551 | 100.00% | 91,624 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.09% | 0.00% | 37,500 | 37,500 | 100.00% | 91,500 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.08% | 0.00% | 32,547 | 32,547 | 100.00% | 79,408 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.05% | 0.00% | 21,099 | 21,099 | 100.00% | 51,482 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 16,401 | 16,401 | 100.00% | 40,182 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.03% | 0.00% | 14,046 | 14,046 | 100.00% | 34,273 | Jun 30, 2024 |
| INVESCO LTD. | 0.03% | - | 14,028 | 14,028 | 100.00% | 34,228 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.02% | 0.00% | 10,043 | 10,043 | 100.00% | 24,505 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 3,196 | 3,196 | 100.00% | 8,000 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 2,987 | 2,987 | 100.00% | 7,288 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 2,642 | 2,642 | 100.00% | 6,394 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 2,209 | 2,209 | 100.00% | 5,390 | Jun 30, 2024 |
| TFC FINANCIAL MANAGEMENT, INC. | 0.00% | 0.00% | 1,500 | 1,500 | 100.00% | 3,660 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | - | 1,055 | 1,055 | 100.00% | 3,000 | Jun 30, 2024 |
| FMR LLC | - | - | 3 | 3 | 100.00% | 7 | Jun 30, 2024 |
Werewolf Therapeutics's largest new institutional shareholder by number of shares is POINT72 ASSET MANAGEMENT, L.P., purchased 319.48K shares, valued at $779.52K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -890,000 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -201,236 | -100.00% | - | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -26,600 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -25,240 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -24,594 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -23,659 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -23,264 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -18,910 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -14,154 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -10,800 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -940 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -202 | -100.00% | - | Jun 30, 2024 |
Werewolf Therapeutics's largest sold out institutional shareholder by shares sold is MONASHEE INVESTMENT MANAGEMENT LLC, sold -0.89M shares, valued at -, as of undefined.
Werewolf Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| ROYCE MICRO-CAP TRUST, INC. | 0.08% | 37,321 | 37,321 | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 79,586 | - | - | Mar 28, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,104 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 748 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 985,614 | -127,773 | -11.48% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 198,743 | 30,605 | 18.20% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,041 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 10,282 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,267 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 71,565 | - | - | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 487 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 6,549 | -875 | -11.79% | Mar 31, 2024 |
| Global X Funds | 0.00% | 7,460 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 6,982 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 752 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 12,075 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 14,596 | - | - | Mar 28, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 10,505 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 5,400 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 252 | - | - | Dec 31, 2023 |
| Dimensional ETF Trust | 0.00% | 24,966 | 10,706 | 75.08% | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 150 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 6,136 | 6,136 | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 199,603 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 565 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 87,421 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 888 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 37,999 | 7,981 | 26.59% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 139 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 9,788 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 2,100 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 3,800 | 2,443 | 180.03% | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 900 | - | - | Mar 28, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 153 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 26 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 2,865 | -17,335 | -85.82% | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 11,421 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 35,981 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,429 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,012 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 2,484 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 200 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,912 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 6,900 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 3,476 | 270 | 8.42% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 44,505 | 1,042 | 2.40% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,870 | - | - | Dec 31, 2023 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 545 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,614 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 86 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 3,999 | - | - | Mar 28, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,425 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 6,000 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 585 | 170 | 40.96% | Mar 31, 2024 |
Werewolf Therapeutics's largest mutual fund holder by % of total assets is "ROYCE MICRO-CAP TRUST, INC.", owning 37.32K shares, compromising 0.08% of its total assets.
Werewolf Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 13 | -79.37% |
| 31 Mar, 24 | 63 | 46.51% |
| 31 Dec, 23 | 43 | 22.86% |
| 30 Sep, 23 | 35 | -2.78% |
| 30 Jun, 23 | 36 | -2.70% |
| 31 Mar, 23 | 37 | -5.13% |
| 31 Dec, 22 | 39 | - |
| 30 Sep, 22 | 39 | - |
| 30 Jun, 22 | 39 | -18.75% |
| 31 Mar, 22 | 48 | -5.88% |
| 31 Dec, 21 | 51 | 21.43% |
| 30 Sep, 21 | 42 | -6.67% |
| 30 Jun, 21 | 45 | - |
As of 30 Jun 24, 13 institutions are holding Werewolf Therapeutics's shares, representing a decrease of -79.37% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 1,450,420 | -95.50% |
| 31 Mar, 24 | 32,252,027 | 16.56% |
| 31 Dec, 23 | 27,669,999 | 15.86% |
| 30 Sep, 23 | 23,883,269 | -0.67% |
| 30 Jun, 23 | 24,045,139 | 0.04% |
| 31 Mar, 23 | 24,035,818 | 15.05% |
| 31 Dec, 22 | 20,891,705 | -0.31% |
| 30 Sep, 22 | 20,956,655 | 9.88% |
| 30 Jun, 22 | 19,072,004 | 0.27% |
| 31 Mar, 22 | 19,019,822 | -0.63% |
| 31 Dec, 21 | 19,140,751 | 0.70% |
| 30 Sep, 21 | 19,007,950 | -3.80% |
| 30 Jun, 21 | 19,758,285 | - |
Werewolf Therapeutics (HOWL) has 1.45M shares outstanding as of 30 Jun 24, down -95.50% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 3.49% | 0.04% |
| 31 Mar, 24 | 88.19% | 1.46% |
| 31 Dec, 23 | 77.61% | 1.72% |
| 30 Sep, 23 | 67.17% | 1.41% |
| 30 Jun, 23 | 69.13% | 1.45% |
| 31 Mar, 23 | 69.10% | 1.32% |
| 31 Dec, 22 | 72.38% | 1.46% |
| 30 Sep, 22 | 70.41% | 1.47% |
| 30 Jun, 22 | 69.31% | 1.44% |
| 31 Mar, 22 | 69.43% | 0.65% |
| 31 Dec, 21 | 103.72% | 2.12% |
| 30 Sep, 21 | 69.91% | 0.56% |
| 30 Jun, 21 | 111.31% | - |
As of 30 Jun 24, Werewolf Therapeutics is held by 3.49% institutional shareholders, representing a 0.04% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | -74.36% |
| 31 Mar, 24 | 39 | 69.57% |
| 31 Dec, 23 | 23 | 76.92% |
| 30 Sep, 23 | 13 | 8.33% |
| 30 Jun, 23 | 12 | -36.84% |
| 31 Mar, 23 | 19 | - |
| 31 Dec, 22 | 19 | 18.75% |
| 30 Sep, 22 | 16 | -5.88% |
| 30 Jun, 22 | 17 | -22.73% |
| 31 Mar, 22 | 22 | -33.33% |
| 31 Dec, 21 | 33 | 94.12% |
| 30 Sep, 21 | 17 | -62.22% |
| 30 Jun, 21 | 45 | - |
10 institutional shareholders have increased their position in HOWL stock as of 30 Jun 24 compared to 39 in the previous quarter (a -74.36% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | - | -100.00% |
| 31 Mar, 24 | 12 | 71.43% |
| 31 Dec, 23 | 7 | 75.00% |
| 30 Sep, 23 | 4 | 33.33% |
| 30 Jun, 23 | 3 | -62.50% |
| 31 Mar, 23 | 8 | -11.11% |
| 31 Dec, 22 | 9 | -18.18% |
| 30 Sep, 22 | 11 | -15.38% |
| 30 Jun, 22 | 13 | -13.33% |
| 31 Mar, 22 | 15 | 114.29% |
| 31 Dec, 21 | 7 | -41.67% |
| 30 Sep, 21 | 12 | - |
| 30 Jun, 21 | - | - |
- institutional shareholders have reduced their position in HOWL stock as of 30 Jun 24 compared to 12 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 13 | -79.37% | 1,450,420 | -95.50% | 3.49% | 0.04% | 10 | -74.36% | - | -100.00% |
| 31 Mar, 24 | 63 | 46.51% | 32,252,027 | 16.56% | 88.19% | 1.46% | 39 | 69.57% | 12 | 71.43% |
| 31 Dec, 23 | 43 | 22.86% | 27,669,999 | 15.86% | 77.61% | 1.72% | 23 | 76.92% | 7 | 75.00% |
| 30 Sep, 23 | 35 | -2.78% | 23,883,269 | -0.67% | 67.17% | 1.41% | 13 | 8.33% | 4 | 33.33% |
| 30 Jun, 23 | 36 | -2.70% | 24,045,139 | 0.04% | 69.13% | 1.45% | 12 | -36.84% | 3 | -62.50% |
| 31 Mar, 23 | 37 | -5.13% | 24,035,818 | 15.05% | 69.10% | 1.32% | 19 | - | 8 | -11.11% |
| 31 Dec, 22 | 39 | - | 20,891,705 | -0.31% | 72.38% | 1.46% | 19 | 18.75% | 9 | -18.18% |
| 30 Sep, 22 | 39 | - | 20,956,655 | 9.88% | 70.41% | 1.47% | 16 | -5.88% | 11 | -15.38% |
| 30 Jun, 22 | 39 | -18.75% | 19,072,004 | 0.27% | 69.31% | 1.44% | 17 | -22.73% | 13 | -13.33% |
| 31 Mar, 22 | 48 | -5.88% | 19,019,822 | -0.63% | 69.43% | 0.65% | 22 | -33.33% | 15 | 114.29% |
| 31 Dec, 21 | 51 | 21.43% | 19,140,751 | 0.70% | 103.72% | 2.12% | 33 | 94.12% | 7 | -41.67% |
| 30 Sep, 21 | 42 | -6.67% | 19,007,950 | -3.80% | 69.91% | 0.56% | 17 | -62.22% | 12 | - |
| 30 Jun, 21 | 45 | - | 19,758,285 | - | 111.31% | - | 45 | - | - | - |
Werewolf Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Werewolf Therapeutics's stock was made by Atkins Michael B. on Jan 04 2024, selling - shares at - per share (valued at -).
Werewolf Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 8 | - | - |
| Q1 2024 | 7 | 1 | 700.00% |
| Q2 2023 | 6 | 1 | 600.00% |
| Q1 2023 | 8 | - | - |
| Q2 2022 | 14 | - | - |
| Q1 2022 | 9 | 2 | 450.00% |
| Q4 2021 | 2 | 3 | 66.67% |
| Q3 2021 | 1 | - | - |
| Q2 2021 | 50 | 40 | 125.00% |
| Q1 2021 | 1 | - | - |
| Q4 2020 | 9 | - | - |
| Q3 2020 | 1 | - | - |
8 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Werewolf Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | 1 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 2 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 15 | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 3 | - | - |
| Q3 2020 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Werewolf Therapeutics's stocks.
Werewolf Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| CYT | Cyteir Therapeutics, Inc. |
| TALS | Tourmaline Bio, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| DBTX | Decibel Therapeutics, Inc. |
| VOR | Vor Biopharma Inc. |
| IKNA | Ikena Oncology, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| CSBR | Champions Oncology, Inc. |
| PASG | Passage Bio, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| MNOV | MediciNova, Inc. |
| THRD | Third Harmonic Bio, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| MOLN | Molecular Partners AG |
| ACET | Adicet Bio, Inc. |
| CELC | Celcuity Inc. |
| ELYM | Eliem Therapeutics, Inc. |
HOWL Ownership FAQ
Who Owns Werewolf Therapeutics?
Werewolf Therapeutics is owned by institutional shareholders (3.49%), insiders (6.23%), and public (90.28%). The largest institutional shareholder of Werewolf Therapeutics is RA CAPITAL MANAGEMENT, L.P. (14.77% of total shares) and the top mutual fund owner is ROYCE MICRO-CAP TRUST, INC. (0.08% of total shares).
Who are the major institutional shareholders of Werewolf Therapeutics?
Werewolf Therapeutics's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., MPM ASSET MANAGEMENT LLC, PFM HEALTH SCIENCES, LP, BIOIMPACT CAPITAL LLC, and BANK OF AMERICA CORP /DE/. The top five shareholders own together 43.76% of the company's share outstanding.
How many Werewolf Therapeutics shareholders are there?
As of Jun 2024, there are 13 institutional shareholders of Werewolf Therapeutics.
What percentage of Werewolf Therapeutics is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 6.14M shares of Werewolf Therapeutics, representing 14.77% of the company's total shares outstanding, valued at $14.99M (as of Jun 2024).
What percentage of Werewolf Therapeutics is owned by MPM ASSET MANAGEMENT LLC?
As of Jun 2024, MPM ASSET MANAGEMENT LLC holds 4.28M shares of Werewolf Therapeutics (HOWL), compromising 10.30% of the company, valued at $10.45M.
What percentage of Werewolf Therapeutics is owned by PFM HEALTH SCIENCES, LP?
PFM HEALTH SCIENCES, LP is the third largest holder of Werewolf Therapeutics. The company owns 3.24M of the company's shares outstanding (worth $7.91M).